Notably, the RBE CTRL group displayed a significantly larger tumor size compared to the RBE DCLK1-KO group, indicating a substantial impairment in subcutaneous tumor development upon DCLK1 deactivation (Fig. 3A). Here, DCLK1 is linked to neoplasm.